​

Legend Biotech (LEGN) Stock Forecast, Price Target & Predictions

OverviewOwnershipChartTranscripts

LEGN Stock Forecast

Legend Biotech (LEGN) stock forecast, based on 19 Wall Street analysts, predicts a 12-month average price target of $59.78, with a high of $75.00 and a low of $24.00. This represents a 64.77% increase from the last price of $36.28.

$20 $31 $42 $53 $64 $75 High: $75 Avg: $59.78 Low: $24 Last Closed Price: $36.28

LEGN Stock Rating

Legend Biotech stock's rating consensus is Buy, based on 19 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 16 Buy (84.21%), 3 Hold (15.79%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 19 0 3 16 Strong Sell Sell Hold Buy Strong Buy

LEGN Price Target Upside V Benchmarks

TypeNameUpside
StockLegend Biotech64.77%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts5520
Avg Price Target$55.20$55.20$56.10
Last Closing Price$36.28$36.28$36.28
Upside/Downside52.15%52.15%54.63%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 26582--15
May, 26592--16
Apr, 26592--16
Mar, 26591--15
Feb, 265112--18
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 03, 2026Ashwani VermaUBS$49.00$36.2835.06%35.06%
Jun 03, 2026H.C. Wainwright$65.00$36.2879.16%79.16%
Jun 01, 2026UBS$50.00$27.1684.09%37.82%
May 13, 2026Leonid TimashevRBC Capital$64.00$28.64123.46%76.41%
May 13, 2026Terence FlynnMorgan Stanley$48.00$27.5674.17%32.30%
Mar 11, 2026Morgan Stanley$49.00$20.27141.74%35.06%
Mar 11, 2026RBC Capital$62.00$20.27205.87%70.89%
Mar 10, 2026Asthika GoonewardeneTruist Financial$70.00$19.56257.87%92.94%
Mar 10, 2026Cui CuiJefferies$69.00$19.56252.76%90.19%
Feb 12, 2026Qize DingRedburn Partners$24.00$18.5429.45%-33.85%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 01, 2026UBSBuyBuyhold
May 27, 2026H.C. WainwrightBuyBuyhold
May 13, 2026RBC CapitalOutperformOutperformhold
May 13, 2026Cowen & Co.HoldHoldhold
May 13, 2026Morgan StanleyOverweightOverweighthold
Mar 10, 2026JefferiesBuyBuyhold
Feb 23, 2026Raymond JamesOutperformOutperformhold
Jan 22, 2026Cowen & Co.BuyHolddowngrade
Jan 20, 2026Raymond JamesOutperformOutperformhold
Jan 07, 2026OppenheimerOutperforminitialise

Financial Forecast

EPS Forecast

$-3 $-2 $-1 $0 $1 $2 $3 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.74$-2.81$-2.94-----
Avg Forecast$-1.56$-1.40$-1.41$-0.86$-0.41$0.55$1.18$1.87
High Forecast$-1.25$-1.17$-1.37$-0.59$0.75$0.90$1.39$2.21
Low Forecast$-1.90$-1.61$-1.46$-1.14$-1.18$0.19$0.94$1.49
Surprise %75.64%100.71%108.51%-----

Revenue Forecast

$0 $600M $1B $2B $2B $3B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$89.79M$117.00M$285.14M-----
Avg Forecast$72.44M$131.97M$297.01M$619.16M$1.02B$1.52B$2.08B$2.58B
High Forecast$84.78M$147.55M$308.48M$645.03M$1.18B$1.53B$2.11B$2.94B
Low Forecast$61.40M$115.57M$285.13M$601.04M$853.64M$1.52B$2.06B$2.18B
Surprise %23.95%-11.34%-3.99%-----

Net Income Forecast

$-550M $-360M $-170M $20M $210M $400M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-386.21M$-446.35M$-518.25M-----
Avg Forecast$-274.51M$-246.49M$-249.08M$-152.60M$-160.21M$140.26M$205.44M$328.97M
High Forecast$-220.11M$-206.67M$-241.41M$-104.04M$132.16M$158.41M$245.33M$389.30M
Low Forecast$-335.32M$-284.32M$-256.76M$-201.15M$-207.88M$34.05M$165.56M$262.73M
Surprise %40.69%81.08%108.06%-----

LEGN Forecast FAQ

Is Legend Biotech stock a buy?

Legend Biotech stock has a consensus rating of Buy, based on 19 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 16 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Legend Biotech is a favorable investment for most analysts.

What is Legend Biotech's price target?

Legend Biotech's price target, set by 19 Wall Street analysts, averages $59.78 over the next 12 months. The price target range spans from $24 at the low end to $75 at the high end, suggesting a potential 64.77% change from the previous closing price of $36.28.

How does Legend Biotech stock forecast compare to its benchmarks?

Legend Biotech's stock forecast shows a 64.77% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Legend Biotech over the past three months?

  • June 2026: 33.33% Strong Buy, 53.33% Buy, 13.33% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 31.25% Strong Buy, 56.25% Buy, 12.50% Hold, 0% Sell, 0% Strong Sell.
  • April 2026: 31.25% Strong Buy, 56.25% Buy, 12.50% Hold, 0% Sell, 0% Strong Sell.

What is Legend Biotech’s EPS forecast?

Legend Biotech's average annual EPS forecast for its fiscal year ending in December 2024 is $-0.86, marking a -70.75% decrease from the reported $-2.94 in 2023. Estimates for the following years are $-0.41 in 2025, $0.55 in 2026, $1.18 in 2027, and $1.87 in 2028.

What is Legend Biotech’s revenue forecast?

Legend Biotech's average annual revenue forecast for its fiscal year ending in December 2024 is $619.16M, reflecting a 117.14% increase from the reported $285.14M in 2023. The forecast for 2025 is $1.02B, followed by $1.52B for 2026, $2.08B for 2027, and $2.58B for 2028.

What is Legend Biotech’s net income forecast?

Legend Biotech's net income forecast for the fiscal year ending in December 2024 stands at $-153M, representing a -70.56% decrease from the reported $-518M in 2023. Projections indicate $-160M in 2025, $140.26M in 2026, $205.44M in 2027, and $328.97M in 2028.